Global Institute of Stem Cell Therapy and Research
1 clinical trials · Sponsor
◉ Watch Global Institute of Stem Cell Therapy and Research
| Record | Firm | Date |
|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus (NCT06789302) | Global Institute of Stem Cell Therapy and Research | 2025-12-01 |
Track Global Institute of Stem Cell Therapy and Research automatically
Every clearance here is in the API, with alerts when new ones post.